Literature DB >> 27481424

Response to Ishimura et al.

Javier Molina-Infante1, Alfredo J Lucendo2, Jose Zamorano3.   

Abstract

Year:  2016        PMID： 27481424     DOI： 10.1038/ajg.2016.218

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  10 in total

1.  Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma.

Authors:  Jose R Cortes; Maria D Rivas; Javier Molina-Infante; Maria A Gonzalez-Nuñez; Moises Perez-G; Juan F Masa; Juan F Sanchez; Jose Zamorano
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

2.  Sustained Acid Suppression by Potassium-Competitive Acid Blocker (P-CAB) May Be An Attractive Treatment Candidate for Patients with Eosinophilic Esophagitis.

Authors:  Norihisa Ishimura; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  Am J Gastroenterol       Date:  2016-08       Impact factor: 10.864

3.  Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.

Authors:  Javier Molina-Infante; Albert J Bredenoord; Edaire Cheng; Evan S Dellon; Glenn T Furuta; Sandeep K Gupta; Ikuo Hirano; David A Katzka; Fouad J Moawad; Marc E Rothenberg; Alain Schoepfer; Stuart J Spechler; Ting Wen; Alex Straumann; Alfredo J Lucendo
Journal:  Gut       Date:  2015-12-18       Impact factor: 23.059

4.  Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.

Authors:  Ting Wen; Evan S Dellon; Fouad J Moawad; Glenn T Furuta; Seema S Aceves; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2014-10-19       Impact factor: 10.793

Review 5.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

6.  Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype.

Authors:  T Kagami; S Sahara; H Ichikawa; T Uotani; M Yamade; M Sugimoto; Y Hamaya; M Iwaizumi; S Osawa; K Sugimoto; H Miyajima; T Furuta
Journal:  Aliment Pharmacol Ther       Date:  2016-03-18       Impact factor: 8.171

7.  Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis.

Authors:  Javier Molina-Infante; Joaquin Rodriguez-Sanchez; Jan Martinek; Bram D van Rhijn; Jana Krajciova; Maria D Rivas; Jesus Barrio; Fouad J Moawad; Carmen Martinez-Alcalá; Albert J Bredenoord; Jose Zamorano; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

8.  ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

Authors:  Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Glenn T Furuta; Chris A Liacouras; David A Katzka
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

Review 9.  Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis.

Authors:  Alfredo J Lucendo; Ángel Arias; Javier Molina-Infante
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-03       Impact factor: 11.382

10.  Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

Authors:  Edaire Cheng; Xi Zhang; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; David H Wang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Gut       Date:  2012-05-12       Impact factor: 23.059
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.